wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q50422379-D9C4D35B-E331-4DA2-8E24-63B47E62D30D
Q50422379-D9C4D35B-E331-4DA2-8E24-63B47E62D30D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50422379-D9C4D35B-E331-4DA2-8E24-63B47E62D30D
Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study.
P2860
Q50422379-D9C4D35B-E331-4DA2-8E24-63B47E62D30D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50422379-D9C4D35B-E331-4DA2-8E24-63B47E62D30D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
97acc4889caef4be909ff9b2d14704475c94d9f5
P2860
Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study.